Barrier-enforcing measures as treatment principle in allergic rhinitis: A systematic review

Current Medical Research and Opinion

Volumn 30, Issue 6, 2014, Pages 1131-1137

  Andersson, Morgan ^a   Greiff, Lennart ^a   Ojeda, Pedro ^b   Wollmer, Per ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Ojeda Clinic   (Spain)

Author keywords

Allergy; Microemulsion; Treatment

Indexed keywords

CELLULOSE; PROTEINASE; SEA WATER; ANTIALLERGIC AGENT;

ALLERGIC RHINITIS; GEL; HUMAN; HYPOTHESIS; LIPID COMPOSITION; MEDLINE; MICROEMULSION; NOSE MUCOSA; PERMEABILITY BARRIER; POWDER; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STUDY DESIGN; SYSTEMATIC REVIEW; THIXOTROPY; ADOLESCENT; ADULT; CHILD; FACTUAL DATABASE; METABOLISM; PATHOPHYSIOLOGY; RESPIRATORY TRACT MUCOSA; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

ADOLESCENT; ADULT; ANTI-ALLERGIC AGENTS; CHILD; DATABASES, FACTUAL; HUMANS; RESPIRATORY MUCOSA; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 84900833308     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2014.882299     Document Type: Review

References (35)

1. Persson CGA, Erjefält JS, Greiff L, et al. Plasma-derived proteins in airway defence, disease and repair of epithelial injury. Eur Respir J 1998;11:958-70
2. Greiff L, Andersson M, Erjefält JS, et al. Loss of size-selectivity at histamine-induced exudation of plasma proteins in human nasal airways. Clin Physiol Funct Imaging 2002;22:28-31
3. Greiff L, Wollmer P, Pipkorn U, Persson CGA. Absorption of 51Cr-EDTA across the human nasal mucosa in the presence of topical histamine. Thorax 1991;146:630-2
4. Greiff L, Wollmer P, Andersson M, Persson CGA. Human nasal absorption of 51Cr-EDTA in smokers and control subjects. Clin Exp Allergy 1994;24:1036-40
5. Salvaggio JE, Cavanaugh JJA, Lowell FC, Leskowitz S. A comparison of the immunologic responses of normal and atopic individuals to intranasally administered antigen. J Allergy 1964;35:62-9
6. Salvaggio JE, Kayman H, Leskowitz S. Immunologic responses of atopic and normal individuals to aerosolized dextran. J Allergy 1966;38:31-9
7. Boucher RC, Ranga V, Pare PD, et al. Effect of histamine and methacholine on guinea pig tracheal permeability to HRP. J Appl Physiol 1978;45:939-48
8. Ranga V, Powers MA, Padilla M, et al. Effect of allergic bronchoconstriction on airways epithelial permeability to large polar solutes in the guinea pig. Am Rev Respir Dis 1983;128:1065-70
9. Richardson JB, Hogg JC, Bouchard T, Hall DL. Localization of antigen in experimental bronchoconstriction in guinea pigs. J Allergy Clin Immunol 1973;52:172-81
10. Walker DC, MacKenzie A, Wiggs BR, et al. The structure of tight junctions in the tracheal epithelium may not correlate with permeability. Cell Tissue Res 1984;235:607-13
11. Cohen MB, Ecker EE, Breitbart JR, Rudolph JA. The rate of absorption of ragweed pollen material from the nose. J Immunol 1930;18:419-25
12. Kontou-Karakitsos K, Salvaggio JE, Mathews KP. Comparative nasal absorption of allergens in atopic and nonatopic subjects. J Allergy Clin Immunol 1975;55:241-8
13. Greiff L, Wollmer P, Svensson C, et al. Effects of seasonal allergic rhinitis on airway mucosal absorption of chromium-51 labelled EDTA. Thorax 1993;48:648-50
14. Greiff L, Lundin S, Svensson C, et al. Reduced airway absorption in seasonal allergic rhinitis. Am J Respir Crit Care Med 1997;156:783-6
15. Wan H, Winton HL, Soeller C, et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 1999;104:123-33
16. Runswick S, Mitchell T, Davies P, et al. Pollen proteolytic enzymes degrade tight junctions. Respirology 2007;12:834-42
17. Vinhas R, Cortes L, Cardoso I, et al. Pollen proteases compromise the airway epithelial barrier through degradation of transmembrane adhesion proteins and lung bioactive peptides. Allergy 2011;66:1088-98
18. Greiff L, Andersson M, Svensson C, et al. Absorption across the mucosa in house dust mite perennial allergic rhinitis. Clin Physiol Funct Imaging 2002;22:55-7
19. Josling P, Steadman S. Use of cellulose powder for the treatment of seasonal allergic rhinitis. Adv Ther 2003;20:213-19
20. Emberlin JC, Lewis RA. A double blind, placebo controlled trial of inert cellulose powder for the relief of symptoms of hay fever in adults. Curr Med Res Opin 2006;22:275-85
21. Emberlin JC, Lewis RA. A double blind, placebo-controlled crossover trial cellulose powder by nasal provocation with Der p1 and Der f1. Curr Med Res Opin 2007;23:2423-31
22. Aberg N, Dahl A, Benson M. A nasally applied cellulose powder in seasonal allergic rhinitis (SAR) in children and adolescents; reduction of symptoms and relation to pollen load. Pediatr Allergy Immunol 2011;22:594-9
23. Klimek L, Gene-Schneider S, Mösges R, Hörmann K. Die 'Pollenschutzcerme' SIMAROline ist wirkungslos bei seisonaler allergischer Rhinitis. Allergologie 2000;23:455-60
24. Olze H, Wustrow TP, Grigorov A. Provokationstest mit Immerfit Pollenschutzcreme bei Patienten mit allergischer Rhinitis. Originalia Erfarungsheilkunde (Heidelb), Medizinverlag Stuttgart, 2002;51:S416-21
25. Schwetz S, Loze H, Melchisedech S, et al. Efficacy of pollen blocker cream in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg 2004;130:979-84
26. Geisthoff UW, Rupp-Classen M, Blum A, Plinkert PK. [The use of lipid containing nasal ointment for allergic rhintis-A therapeutic option? A bicentric, prospective, open, randomized, controlled clinical study] HNO 2005;53:1047-50
27. Andersson M, Greiff L, Wollmer P. Nasal treatment with a microemulsion reduces allergen challenge-induced symptoms and signs of allergic rhinitis. Acta Otolaryngol 2008;128:666-9
28. Andersson M, Greiff L, Wollmer P. Effects of a topical microemulsion in house dust mite allergic rhinitis. Basic Clin Pharmacol Toxicol 2011;108: 146-8
29. Ojeda P, Piqué N, Alonso A, et al. A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study). Allergy Asthma Clin Immunol 2013;9:32
30. Luond-Valeskeviciute I, Haenggi B, Gruenwald J. Efficacy of three thixotropic nasal spray preparations on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit. Available at: www.webmedcen-tral.com/article-view/993 [Last accessed October 2013]
31. Weston LA, Mö sges R. Treating seasonal allergic rhinoconjunctivitis with liposomal nasal spray. Allergologie 2010;33:196-204
32. Böhm M, Avgitidou G, El Hassan E, Mösges R. Liposomes: a new non-pharmacological therapy concept for seasonal-Allergic-rhinoconjunctivitis. Eur Arch Otorhinolaryngol 2012;269:495-502
33. Cingi C, Unlu HH, Songu M, et al. Seawater gel in allergic rhinitis: entrapment and mucociliary effect and mucociliary clearance compared with saline. Ther Adv Respir Dis 2010;4:13-18
34. Bufe A. A simple advice for the prevention of pollen-induced allergic rhinitis. Int Arch Allergy Immunol 2000;121:85-6
35. Bousquet J, Van Cauwenberger P, Bachert C, et al. Requirements for medication commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy 2003;58:192-7